The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme
出版年份 2013 全文链接
标题
The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme
作者
关键词
Glioblastoma multiforme, Prognosis, c-Met, Immunohistochemistry
出版物
Clinical & Translational Oncology
Volume 16, Issue 2, Pages 173-177
出版商
Springer Nature
发表日期
2013-06-05
DOI
10.1007/s12094-013-1059-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Towards Tailored Therapy of Glioblastoma Multiforme
- (2014) N.H. Rekers et al. JOURNAL OF CHEMOTHERAPY
- An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth
- (2012) Fadila Guessous et al. Anti-Cancer Agents in Medicinal Chemistry
- Progress in cancer therapy targeting c-Met signaling pathway
- (2012) Kyung Hee Jung et al. ARCHIVES OF PHARMACAL RESEARCH
- A Novel Kinase Inhibitor, INCB28060, Blocks c-MET-Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3
- (2011) X. Liu et al. CLINICAL CANCER RESEARCH
- HGF/c-MET Targeted Therapeutics: Novel Strategies for Cancer Medicine
- (2011) Timothy A. Yap et al. CURRENT DRUG TARGETS
- Molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies
- (2011) K. Masui et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma
- (2011) Q. Xie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- -Secretase Inhibitors Enhance Temozolomide Treatment of Human Gliomas by Inhibiting Neurosphere Repopulation and Xenograft Recurrence
- (2010) C. A. Gilbert et al. CANCER RESEARCH
- C-MET as a new therapeutic target for the development of novel anticancer drugs
- (2010) Israel Cañadas et al. Clinical & Translational Oncology
- Survival comparison between glioblastoma multiforme and other incurable cancers
- (2010) B. Tran et al. JOURNAL OF CLINICAL NEUROSCIENCE
- c-Met expression is associated with time to recurrence in patients with glioblastoma multiforme
- (2010) Wei Liu et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Expression of hepatocyte growth factor and its receptor c-Met in human pituitary adenomas
- (2010) X.-Z. Hou et al. NEURO-ONCOLOGY
- Glioblastoma multiforme: a review of therapeutic targets
- (2009) Okezie O Kanu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo
- (2009) S. G. Buchanan et al. MOLECULAR CANCER THERAPEUTICS
- The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
- (2009) James W Welsh et al. Radiation Oncology
- Prognostic significance of c-Met expression in glioblastomas
- (2008) Doo-Sik Kong et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now